Research Study

We are testing whether a drug can prevent Coronavirus infection

in people who have been close contacts of a person who has Coronavirus.

We are currently recruiting from the greater Melbourne, Bendigo and Ballarat areas. Recruitment location may change in the future so please check this website regularly.

Please check the lists of inclusions and exclusions below.

If after you check those lists, you think the study is suitable for you and you might like to join, please enter your contact details and we will be in touch.

Be aged 18-80.

AND

Have had close contact with a person who has Coronavirus infection.

AND

That contact was within the last 72 hours.

AND

You have since tested negative for Coronavirus on a PCR or a rapid antigen test.

AND

The contact occurred in any of the following situations: a home, an indoor work environment or a social or religious gathering, function or ceremony of less than 30 people.

You are pregnant or breastfeeding.

OR

You are taking any of the following medications. They could increase the risk for side effects from the study drug. Medications: warfarin, amiodarone, verapamil, diltiazem, spironolactone, quinidine, erythromycin, clarithromycin, fusidic acid, ketoconazole, itraconazole, cobicistat, ritonavir, indinavir, didanosine (DDI), ciclosporine or tacrolimus.

OR

You have had any of: concussion, head injury, stroke or TIA (transient ischaemic attack) in the last 6 months or you have dementia. These conditions could increase the risk of side effects from the study drug.

OR

You have a history of epilepsy or severe asthma.

If you have checked the lists above and if you think the study is suitable for you and you might like to join,

Then enter your contact details and we will be in touch with more information.

First name

Last name

Mobile

This trial is sponsored by Monash University and is being run by The Florey Institute of Neuroscience and Mental Health trading as Neuroscience Trials Australia (NTA). Information collected in the REDCap database is used strictly for the trial and to contact participants only.